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ABSTRACT Alveolar echinococcosis (AE) is a lethal disease caused by infection with
the metacestode stage of the helminth Echinococcus multilocularis, which develops
into a tumorlike mass in susceptible intermediate hosts. The growth potential of this
parasite stage is directly linked to the nature of the surrounding periparasitic
immune-mediated processes. In a ﬁrst step (experiment 1), mice were orally infected
with E. multilocularis eggs, to be used for assessing the hepatic expression proﬁles of
15 selected cytokine and chemokine genes related to acquired immunity from 21 to
120 days postinfection. The early stage of infection in immunocompetent animals
was marked by a mixed Th1/Th2 immune response, as characterized by the concom-
itant presence of gamma interferon (IFN-) and interleukin-4 (IL-4) and their related
chemokines. At the late stage of AE, the proﬁle extended to a combined tolerogenic
mode including Foxp3, IL-10, and transforming growth factor beta (TGF-) as key
components. In a second step (experiment 2), the effect of T regulatory cell (Treg)
deﬁciency on metacestode growth was assessed in E. multilocularis-infected DEREG
(depletion of regulatory T cells) mice upon induction of Treg deﬁciency with diph-
theria toxin (DT). The parasite lesions were signiﬁcantly smaller in the livers of
treated mice than in corresponding control groups. Foxp3 Tregs appear to be one
of the key players in immune-regulatory processes favoring metacestode survival by
affecting antigen presentation and suppressing Th1-type immune responses. For
these reasons, we suggest that affecting Foxp3 Tregs could offer an attractive tar-
get in the development of an immunotherapy against AE.
KEYWORDS alveolar echinococcosis, regulatory T cells, Th1 immunity, oral infection,
Treg deﬁciency
Alveolar echinococcosis (AE) is a severe zoonotic helminth disease, which is fatal topatients if not appropriately diagnosed and treated (1). The adult tapeworms of
Echinococcus multilocularis persist in the intestine of their ﬁnal hosts (mainly canids,
such as foxes, dogs, raccoon dogs, and coyotes) and produce infectious eggs that are
released into the environment with the feces. Once these eggs are ingested by
intermediate hosts (i.e., rodents, and accidentally humans), they hatch, and released
oncospheres penetrate through the small intestinal mucosa. From there, they are
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transported via portal blood ﬂow to the liver. Here the larvae (metacestodes) establish
within the liver parenchyma, with a subsequent continuous growth and maturation
process. The larval mass gradually proliferates and inﬁltrates the liver parenchyma, thus
destroying the surrounding host tissue, and resembles a slow-growing malignant
neoplasm in both its macroscopic appearance and behavior (2). The disease AE is thus
caused by a chronically progressing hepatic damage due to the continuous prolifera-
tion of the metacestode (larval stage) of E. multilocularis in a tumorlike way (3). The
metacestode tissue is also able to metastasize, thus also progressively invading other
sites such as lungs and brain, among others (4). The kind and type of the immune
response elicited by E. multilocularis infection have an impact on the development of
clinical signs and outcome of disease (2, 3), ranging from resistance (self-cure) to high
susceptibility characterized by evolving disease and subsequent fatality (4). Human
patients with a Th2-orientated immunity are more likely to develop chronic AE, while
those with Th1 cell activation more commonly show reduced or even aborted parasites
(visible as died-out lesions) and thus protection (3, 4). In human AE, CD4 CD25 T
regulatory cells (Tregs), which play a major role in the regulation of immune response,
appeared to be upregulated during the time course of the disease. This upregulation
appears to be associated with the blunting of immune responses to speciﬁc antigens
and/or to the suppression of the secretion of proinﬂammatory cytokines, especially
through high interleukin-10 (IL-10) and transforming growth factor beta 1 (TGF-1)
production (4).
The most common experimental infection model of AE so far is provided by the
secondary murine infection model. In this model, the infection is induced through the
intraperitoneal (i.p.) or intrahepatic injection of E. multilocularis metacestode tissue
suspension. The immune reaction is characterized mainly by a Th1-oriented response
during the early stage of infection (approximately until 1 month postinfection [p.i.]),
which gradually shifts toward a more dominant Th2-oriented response within the 2 to
4 subsequent months but still remains a mixture of Th1/Th2 within the chronic phase
of infection. During this chronic phase, proinﬂammatory cytokines are expressed in the
periparasitic granuloma. The infected mice show a partial/relative protective immunity
mainly by means of periparasitic liver ﬁbrosis and central parasite tissue necrosis that
lead to a restricted parasite growth (5, 6). Also, CD4 CD25 Tregs appeared to act as
a central immune cell population in triggering periparasitic anergy (7). In a similar
context, E. multilocularis-infected DEREG (depletion of regulatory T cells) mice exhibited
a signiﬁcantly lower parasite mass/load when they were treated with diphteria toxin
(DT) to induce Treg deﬁciency than non-DT-treated controls (8). However, the natural
mode of infection, or primary infection, of intermediate hosts with E. multilocularis
results from peroral uptake of infectious eggs, and unlike the above-described second-
ary infection model, this peroral infection includes also the ﬁrst phase of intrahepatic
(postoncospheral) parasite development, which might be crucial in determining the
early immune response during AE. Such a model is seldom applied in experimental
infection due to the high risk for the staff and thus the necessity of working in a
biosafety level 3 facility. Some studies used a primary infection model, but these were
restricted to the description of conventional humoral immune reactions (9, 10) or of
morphological growth behavior in different mouse strains (11, 12). No study has
reported on the host immune response in primary murine AE, especially not addressing
the immunomodulatory events induced by the parasite and its subsequent effect on
the host immune response.
The objectives of this study were to apply the mouse model of primary E. multil-
ocularis infection such as (i) to elucidate immunological key parameters occurring
under primary infection and (ii) to explore whether Foxp3 Tregs could be putatively
tackled as an immunotherapeutic target against primary E. multilocularis infection.
RESULTS
To get a more complete picture on the inﬂuence of the parasite-induced host
immune response following primary infection, in experiment 1 the expression levels of
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15 key cytokines and chemokines were measured in the spleen applying reverse
transcription-quantitative PCR (qRT-PCR) at 21, 45, 60, and 120 days p.i.
Inﬂammatory and proinﬂammatory cytokines. Mice primarily infected with E.
multilocularis eggs showed signiﬁcant differences during the course of proinﬂammatory
cytokine development in the spleen during 21 to 120 days (sampling days 21, 45, 60,
120) of expressional assessment by real-time quantitative PCR (RT-qPCR), compared
with noninfected control mice: tumor necrosis factor alpha (TNF-) mRNA expression
was increased at day 21 p.i. (P  0.05). Subsequently, it rapidly decreased and
maintained a low expression level during day 45 and day 120 p.i. (Fig. 1A). IL-1 mRNA
expression was signiﬁcantly higher than in control mice at day 21 p.i. (P  0.05),
dropped at day 45 p.i., reincreased, and reached its maximum at day 120 p.i. (P 0.05).
Infected mice displayed a signiﬁcant increase in IL-6 mRNA expression at day 60 p.i.
(P  0.05) (Fig. 1C).
Th1/Th17 cytokines and related chemokines. (i) Th1-related cytokines and
chemokines. In the spleen of infected mice, gamma interferon (IFN-) mRNA expres-
sion was signiﬁcantly increased at day 21 p.i. (P  0.05). It subsequently decreased to
normal levels during days 45 to 120 p.i. (Fig. 2A). In parallel with IFN-, the level of
CXCL9 mRNA expression in infected mice was markedly higher at day 21 p.i. (P  0.05)
(Fig. 2B). The expression level of CXCL10 mRNA was also markedly increased at day 21
p.i. (P  0.05), but it was increased again at day 120 p.i. despite a subsequent drop at
days 45 and 60 p.i. (Fig. 2C).
(ii) Th17-related cytokines and chemokines. In the spleen of infected mice, IL-17A
mRNA expression increased and then remained at a high expression level at days 45
and 120 p.i. (P  0.05), with a relative decrease at day 60 p.i. (Fig. 2D). However, CCL5
mRNA expression was signiﬁcantly increased only at day 120 p.i. compared to control
mice (P  0.05) (Fig. 2E).
FIG 1 Course of proinﬂammatory cytokine gene expression in the spleen of mice following peroral E. multilocularis infection (measured
by qRT-PCR). (A) TNF-; (B) IL-1; (C) IL-6. Data represent means SD from three independent experiments with a total of 18 mice in each
group (6 mice per group in each independent experiment). Comparison between groups was performed using a two-way ANOVA with
Bonferroni’s multiple comparison posttest for statistical analysis. *, P  0.05. Control, noninfected mice; AE, E. multilocularis-infected mice;
AU, arbitrary units.
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Th2 cytokines and related chemokines. In the spleen of infected mice, IL-4 mRNA
expression was increased at day 21 p.i. (P  0.05), compared to controls. IL-4 subse-
quently decreased and then remained at a low expression level around the middle
stage of E. multilocularis infection. It reincreased markedly at day 120 p.i. (P 0.05) (Fig.
3A). However, CCL8 and CCL12 mRNA expression was signiﬁcantly increased only at day
21 p.i. (P  0.05) (Fig. 3B and C).
Treg-related nuclear transcription factor and cytokines. In the spleen of infected
mice, Foxp3 mRNA expression was increased at days 21 and 45 p.i., compared to
controls. After a drop at day 60 p.i., Foxp3 expression was markedly reincreased at day
120 p.i. (P  0.05) (Fig. 4A). TGF-1 mRNA expression was increased at days 21 and 45
p.i. (P  0.05) (Fig. 4B), while CTLA-4 mRNA expression was signiﬁcantly increased at
day 21 p.i. (P  0.05) (Fig. 4C). IL-10 mRNA expression was signiﬁcantly increased at 21
and 45 days p.i. (P  0.05).
Effect of E. multilocularis egg infection on serum cytokine levels. To determine
whether E. multilocularis egg infection impacts on the immune proﬁle of systemic
immunity, we measured the concentration of Th-related cytokines in the serum. Thus,
the IFN- level in serum was increased at day 45 p.i. in infected mice (P 0.05) and then
maintained a higher level than in noninfected animals (Fig. 5A). The IL-17A level in
serum showed no statistically signiﬁcant difference between AE mice and controls;
however, another Th17-related cytokine, IL-22, was observed to be much higher on day
120 p.i. in AE mice (P  0.05) than in noninfected controls (Fig. 5B and C). With regard
to Th2-related cytokines, IL-4 levels in serum showed no statistically signiﬁcant differ-
ences between AE mice and controls, whereas IL-5 yielded higher levels at day 120 p.i.
in AE mice (P  0.05) than in noninfected controls (Fig. 5D and E). The IL-10 level in
serum was increased at day 120 p.i. in AE mice (P  0.05) compared to noninfected
controls (Fig. 5F).
FIG 2 Course of Th1/Th17-related cytokine and chemokine gene expression in the spleen of mice following peroral E. multilocularis
infection (measured by qRT-PCR). (A) IFN-; (B) CXCL-9; (C) CXCL-10; (D) IL-17A; (E) CCL-5. Data represent means  SD from three
independent experiments with a total of 18 mice in each group (6 mice per group in each independent experiment). Comparison between
groups was performed using a two-way ANOVA with Bonferroni’s multiple comparison posttest for statistical analysis. *, P 0.005. Control,
noninfected mice; AE, E. multilocularis-infected mice; AU, arbitrary units.
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Foxp3 Tregs as a potential immunotherapeutic target against primary AE.
Experiment 2 focused on the potential role of Foxp3 Tregs in the immunological ﬁght
against primary AE. Infected mice with active or depleted Foxp3 expression were
assessed for their Th1/Th2-related and Treg/Th17-related cytokines, antigen-presenting
cell (APC) activation, and the generation as well as the function of Tregs. Abrogation of
Treg function was obtained in infected DEREG mice by DT treatment (intraperitoneal
injection, 110 ng/mouse), initiated 3 weeks p.i. and subsequently maintained for 4
weeks (with 3 applications/week). Two mice (one from the treatment group and
another from the nontreated group) were excluded for statistical analysis because of
subcutaneous lesion. Foxp3 Treg-depleted mice had parasite lesions in the liver that
were smaller on average than those of nondepleted controls (Fig. 6A and B). However,
the numbers of hepatic lesions were similar in the two groups (Fig. 6C). This can be
explained by the fact that depletion took place after the primary establishment of the
oncospheres within the liver had occurred.
Th cells from Foxp3 Treg-depleted mice were oriented toward a much stronger
Th1 immune response than those from control mice. This appeared as a signiﬁcantly
higher IFN- (Fig. 6D and E) and a lower IL-10 (Fig. 6F and G) production. However, the
difference respective to Th2 and Th17 immune response orientation was not signiﬁcant
(these data are supported by Fig. S1 in the supplemental material).
Both subsets of APCs, CD11b and CD11c cells, displayed a higher frequency of
CD80 in depleted mice than in controls (Fig. 7A to D). However, no difference in CD86
frequency was present (Fig. 7E and F).
DISCUSSION
The main immunological characteristic upon infection with E. multilocularis leading
to AE is a progressively increasing tolerance status of the host, marked by a down-
regulation of periparasitic immune effector mechanisms. This anergic property devel-
FIG 3 Course of Th2-related cytokine and chemokine gene expression in the spleen of mice following peroral E. multilocularis infection
(measured by qRT-PCR). (A) IL-4; (B) CCL-8; (C) CCL-12. Data represent means  SD from three independent experiments with a total of
18 mice in each group (6 mice per group in each independent experiment). Comparison between groups was performed using a two-way
ANOVA with Bonferroni’s multiple comparison posttest for statistical analysis. *, P  0.05. Control, noninfected mice; AE, E. multilocularis-
infected mice; AU, arbitrary units.
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ops and increases over time and reaches its maximum at the late stage of disease, both
in naturally infected humans (13) and in mice experimentally infected via i.p. or
intrahepatic metacestode inoculation (14). However, data on the postinfection cellular
immune responses following peroral infection of mice with E. multilocularis eggs, which
mimics the natural infection route for human AE patients, have scarcely been published
(9). For the ﬁrst time, we could now show that in mice subjected to primary infection
with E. multilocularis eggs (Fig. 8), (i) there was a parallel expression of Foxp3 and
CTLA-4 plus IL-10 at a very early stage of infection, (ii) IL-17A was involved at the
early/middle stage of the immune response and remained markedly expressed all along
the course of infection, (iii) a parallel additional pattern of cytokines and related
chemokines indicated their continuous role in maintaining the homing of immune cells
at different infection stages, and (iv) most importantly, Foxp3 Tregs were found to be
an important immunological factor promoting E. multilocularis proliferative activity in
mice. We showed that downregulation of Foxp3 Tregs might be a strategy to
reinforce the immunological periparasitic control of intrahepatic E. multilocularis infec-
tion.
The messenger RNAs of proinﬂammatory cytokines TNF-, IL-1, and IL-6, which
initiate the ﬁbrotic process, have been demonstrated in macrophages located at the
periphery of granulomas (15). In the present study, we showed that mRNA levels of
TNF-, IL-1, and IL-6 in the spleen were developing alternately during the different
stages of primary E. multilocularis infection. The initial increase of TNF- and IL-1
expression with a subsequent dramatic decrease after day 45 p.i. is in accordance with
previous reports (5). TNF- appeared to have a protective role against E. multilocularis
(16, 17). Patients with active AE, i.e., a metacestode proliferating in the periphery and
occasionally showing central necrosis, also displayed higher expression of TNF-mRNA
in surrounding cells. The activation of pathogen recognition receptors of immune cells,
FIG 4 Course of Treg nuclear transcription factor and cytokine gene expression in the spleen of mice following peroral E. multilocularis
infection (measured by qRT-PCR). (A) Foxp3; (B) TGF-1; (C) CTLA-4; (D) IL-10. Data represent means  SD from three independent
experiments with a total of 18 mice in each group (6 mice per group in each independent experiment). Comparison between groups was
performed using a one-way ANOVA with Bonferroni’s multiple comparison posttest for statistical analysis. *, P 0.05. Control, noninfected
mice; AE, E. multilocularis-infected mice; AU, arbitrary units.
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such as monocytes and macrophages, stimulates a range of signaling pathways,
including NF-B, which may enhance the transcription of inﬂammatory cytokines genes
such as those encoding IL-6, TNF-, and IL-1. TNF- and IL-1 also activate transcrip-
tion factors to produce IL-6 (18). That could explain the early expression of TNF- and
IL-1 in our present study. IL-6 then appeared, presumably to sustain the inﬂammatory
response at the middle infection stage, and possibly also to transmit/represent a
warning signal in the event of tissue damage. Secretion of the proinﬂammatory
cytokines IL-1 and IL-18 by peripheral blood mononuclear cells (PBMCs) of AE patients
appeared to be reduced in response to E. multilocularis metacestodes, compared to
controls (19). In the present study, however, IL-1 was highly expressed at the early
stage, subsequently decreased at the middle stage, but reincreased at the late stage.
Such selective dynamics of proinﬂammatory cytokine release may maintain the peripa-
rasitic immune inﬁltrate from the very early stage of infection to the chronic stage.
Several concordant previous observations had shown that PBMCs of AE patients as
well as spleen or lymph node cells of experimentally infected mice exhibited a markedly
and steadily increasing Th2 orientation of the immune response (20). Our previous
studies also documented a biphasic curve of IL-4 mRNA expression, with a very early
peak at 2 to 8 days after intrahepatic infection (5), which was also found in the present
study. The early expression of IL-4 mRNA might be crucial to prime naive CD4 T cells
into differentiated Th2-type cells (21) and to prevent the development of an immune-
mediated antiparasitic resistance (22, 23). In the present study, spleen cells displayed an
increase of IL-10 mRNA at the early stage of infection, but with a delayed increase of
Foxp3 mRNA at the middle stage and a decrease of IFN- mRNA at the late infection
stage. Furthermore, there was an increase of IL-10 expression in the serum at the late
infection stage. This delayed increase of Foxp3/decrease of IFN- and increase of serum
IL-10 level at the late infection stage match previous observations at the late stage of
infection of human AE (24–26) and are in agreement with the data usually reported
FIG 5 Course of Th-related serum cytokine expression levels following peroral E. multilocularis infection (measured by mesoscale). (A) IFN-; (B) IL-17A; (C) IL-22;
(D) IL-4; (E) IL-5; (F) IL-10. Data represent means  SD for 6 mice in each group. Comparison between groups was performed using a two-way ANOVA with
Bonferroni’s multiple comparison posttest for statistical analysis. *, P  0.05. Control, noninfected mice; AE, E. multilocularis-infected mice.
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from lymphocyte studies in secondarily infected mice (27). This combined cytokine
proﬁle is highly indicative of a strategy from the parasite to evade host immune
response effectors (5, 13, 20).
There is growing evidence that parasite-induced immunomodulation is a hallmark
of the pathophysiology of AE (28). Tregs play a dominant role in the suppression of
autoimmune pathologies, as rescue of Treg number or function in model systems can
both prevent and reverse disease (29). In the mouse, a lack of CD4 Foxp3 Tregs
results in increased autoimmunity, and adoptive transfer of Tregs prevents and reverses
autoimmunity (30). Overexpression of regulatory cytokine genes in Tregs, such as IL-10
and TGF-, characterizes immune tolerance in a number of parasitic disease models
(31). In AE, earlier studies have shown that CD4 CD25 Tregs were upregulated in
FIG 6 Foxp3 Treg-inducible knockdown as a potential immunotherapeutic target against primary AE- and Th-related immune response (assessed by FACS).
(A) Representative picture of individual parasite lesions (indicated by arrows) in the liver of AE-DEREG DT and AE-DEREG DT mice at 3 months postinfection.
(B) Lesion size in the liver of AE-DEREG DT and AE-DEREG DT mice 3 months postinfection. (C) Number of lesions in the liver from AE-DEREG DT and
AE-DEREG DT mice 3 months postinfection. (D) Frequency of IFN- T cells within CD4 T cells in spleen cells from AE-DEREG DT and AE-DEREG DT mice
at 3 months postinfection. (E) Representative scatter plots of IFN- T cells within CD4 T cells in spleen cells from AE-DEREG DT and AE-DEREG DT mice
3 months postinfection. (F) Frequency of IL-10 T cells within CD4 T cells in spleen cells from AE-DEREG DT and AE-DEREG DT mice. (G) Representative
scatter plots of IL-10 T cells within CD4 T cells in spleen cells from AE-DEREG DT and AE-DEREG DT mice 3 months postinfection. Data represent
means  SD for a total of 6 mice in the noninfected control group and 5 mice in the AE group (AE-DEREG DT and AE-DEREG DT) after excluding the
mice with subcutaneous lesions or no lesion in the liver. Comparison between groups was performed using a two-way ANOVA with Bonferroni’s multiple
comparison posttest for statistical analysis. *, P 0.025. DEREG DT, foxp3-inducible knockdown mice (DEREG mice) without DT application; DEREG DT, DEREG
mice with DT application; AE-DEREG DT, E. multilocularis-infected DEREG without DT application; AE-DEREG DT, E. multilocularis-infected DEREG mice with
DT application. Control, noninfected mice. DT application started 1 month postinfection and was maintained for 1 month, and the mice were sacriﬁced at 3
months postinfection.
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peritoneal exudate cells (PECs) from wild-type (WT) E. multilocularis-infected mice (32).
The same Treg lines seem also to be upregulated in human AE patients (33). Tregs
appear to be one of the key immune subsets to mediate the progressing anergic
immune status in chronic infection (5, 34, 35). The smaller AE lesion sizes in the liver of
Foxp3 Treg-depleted mice from our study corroborate the importance of Tregs in AE,
a phenomenon that was associated with a higher Th1 immune response, a lower IL-10
production, no difference of Th2/Th17 immunity, and upregulation of APC activation.
In our primary infection model, the late infection was characterized by a strong
Foxp3 expression and weak expression of most mediators, suggesting that their
production is suppressed by Tregs. Understanding how Foxp3 Tregs regulate the
immune process in AE could help ﬁnd new immunotherapeutic targets. Future studies
should further explore immunomodulatory parameters such as Foxp3 Treg-blocking
FIG 7 Foxp3 Treg-inducible knockdown against primary AE and its related APC activation (assessed by FACS). (A) CD80 frequency within CD11b APCs in
spleen cells from AE-DEREG DT and AE-DEREG DT mice at 3 months postinfection. (B) Representative scatter plots of CD80 cells within CD11b APCs in
spleen cells from AE-DEREG DT and AE-DEREG DT mice at 3 months postinfection. (C) CD80 frequency within CD11c APCs in spleen cells from AE-DEREG
DT and AE-DEREG DT mice at 3 months postinfection. (D) Representative scatter plots of CD80 cells within CD11c APCs in spleen cells from AE-DEREG
DT and AE-DEREG DT mice at 3 months postinfection. (E) CD86 frequency within CD11b APCs in spleen cells from AE-DEREG DT and AE-DEREG DT mice
at 3 months postinfection. (F) CD86 frequency within CD11c APCs in spleen cells from AE-DEREG DT and AE-DEREG DT mice at 3 months postinfection.
Data represent means SD for a total of 6 mice in noninfected control groups and 5 mice in the AE groups (AE-DEREG DT and AE-DEREG DT) after excluding
mice developing subcutaneous lesions or presenting no lesion at all. Comparison between groups was performed using a two-way ANOVA with Bonferroni’s
multiple-comparison posttest for statistical analysis. *, P 0.05. DEREG DT, foxp3-inducible knockdown mice (DEREG mice) without DT application; DEREG DT,
DEREG mice with DT application; AE-DEREG DT, E. multilocularis-infected DEREG without DT application; AE-DEREG DT, E. multilocularis-infected DEREG mice
with DT application. Control, noninfected mice. DT application started 1 month postinfection and was maintained for 1 month, and mice were sacriﬁced at 3
months postinfection.
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agents (i.e., PD1/PD-L1 blockade). The ﬁnal aim should be to convert the immunological
anergy during chronic disease into a more proactive, Th1-oriented immunity, with
potential reduction or even inactivation of the metacestode tissue, and thus a healing
option for the host. Such an approach could even be coupled to a parasitostatic
benzimidazole medication in order to obtain therapeutic synergy.
MATERIALS AND METHODS
Ethics statement. The animal study was performed in strict accordance with the recommendations
of the Swiss Guidelines for the Care and Use of Laboratory Animals. The protocol was approved by the
governmental Commission for Animal Experimentation of the Canton of Bern (approvals no. BE103/11
and BE112/14).
Experimental design, parasite sampling, and histological examinations. (i) Experiment 1.
Immune-related gene expression during primary AE. To get a more complete picture on the inﬂuence
of the parasite-induced host immune response following primary infection, the expression of 18 key
cytokines and chemokines (5) was measured in the spleen at 21, 45, 60, and 120 days following egg
infection, using qRT-PCR. Three independent experiments were carried out; each experimental group at
each sampling time point included 6 animals. For one independent experiment, 48 female C57/BL6 mice
aged between 8 and 10 weeks were randomly divided into two groups: the AE group (perorally infected
with E. multilocularis eggs; see below) and the noninfected controls. At days 21, 45, 60, and 120 p.i., mice
were euthanized in a CO2 chamber and spleens were harvested for total RNA extraction and subsequent
qRT-PCR analyses. The mice with subcutaneous lesion and/or no lesion in the liver were excluded.
(ii) Experiment 2. Foxp3 Tregs as therapy target against primary AE. To explore the potential
role of Foxp3 Tregs in protection against primary AE, Th1/Th2-related and Treg/Th17-related cytokines,
antigen-presenting cell activation, and the generation of Tregs and their functions were studied at the
different disease stages in an experimental model with active or depleted Foxp3 Tregs. DEREG
(depletion of regulatory T cells) mice of the C57/BL6 background with or without DT application, all aged
between 8 and 10 weeks, were used to assess whether Foxp3 could be used as a target for treatment
against AE. Age- and gender-matched littermates were used for mock-infected control groups. Each
group included 6 animals if not stated otherwise, and the experiment was performed with 24 mice in
total (divided into 4 groups, including AE-DEREG DT, control-DEREG DT, AE-DEREG DT, and control-
DEREG DT). In DEREG mice, a diphtheria toxin (DT) receptor together with an enhanced green
FIG 8 Course of the gene expression of innate immunity and proinﬂammatory cytokines (a), Th1/Th17-related cytokines
and chemokines (b), Th2-related cytokines and chemokines (c), and Treg-related cytokines (d). p.i., postinfection.
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ﬂuorescent protein (eGFP) is expressed under the control of the Foxp3 promoter. Therefore, depletion of
Treg cells can be achieved by appropriate DT application (36). As shown elsewhere (37), in naive DEREG
mice a subset of Foxp3 Treg cells lacking the DT receptor (DTR) and GFP expression are not affected
by the treatment. All animals were bred in-house, conﬁrmed by genotyping for GFP and DTR genes (38),
and additionally monitored by daily inspection, including the assessment of the appearance of health
status and putative weight loss or gain during the whole course of the experiment.
Parasite and experimental infection. E. multilocularis eggs were isolated from a naturally E.
multilocularis-infected dog, which was euthanized at the Small Animal Clinic of the Vetsuisse Faculty due
to a noninfectious disease. Infection with E. multilocularis was detected upon routine necropsy investi-
gation by pathologists. To prepare the parasite eggs for subsequent infection of mice, the dog intestine
was removed under appropriate safety precautions and cut into 4 pieces. After longitudinal opening of
the intestinal segments, the worm-containing mucus was scraped out and put into petri dishes
containing sterile water. Subsequently, the mucosal suspension was serially ﬁltered through a 500-m
and then a 250-mmetal sieve, by concurrently disrupting the worms with an inversed 2-ml syringe top.
This suspension was further ﬁltered through a 105-m nylon sieve. The eggs were then washed by
repeated sedimentation (1  g, 30 min, room temperature) in sterile water containing 1% penicillin-
streptomycin and stored in the same solution at 4°C. For primary infection of mice, animals received
approximately 400 eggs suspended in 100 l sterile water by peroral gavage. Control mice (mock
infection) received 100 l water only. All animal infections were performed in a biosafety level 3 unit
(permit no. A990006/3).
Treg cell depletion. To explore whether Foxp3 could be putatively tackled as an immunotherapeutic
target against primary E. multilocularis infection, E. multilocularis-infected DEREG mice with or without DT
application and corresponding control WT littermates were investigated for the growth kinetics of the
individually developing intrahepatic parasite lesions. DEREG-C57/BL6 mice (DEREG) and their WT litter-
mate controls were used either as infected animals or as noninfected controls. All mice belonging to the
Treg cell depletion group received 110 ng of DT i.p. (Calbiochem, Merck, Germany) dissolved in 100 l
phosphate-buffered saline (PBS) starting at 3 weeks postinfection and maintained for 4 weeks with a
frequency of 3 applications/week. Successful depletion and rebound of Treg cells were conﬁrmed by
ﬂow-cytometric analysis based on the detection of the FoxP3eGFP signal in splenic leukocytes. Infected
mice were daily monitored for survival/well-being and morbidity.
Parasite lesion quantiﬁcation and spleen sampling. All mice orally infected with E. multilocularis
eggs and their noninfected controls were euthanized in a CO2 chamber at the end of DT application. At
necropsy, the number and size (diameter) of the individual liver lesions (each caused by one developing
oncosphere, originating from one parasite egg) were recorded. The mice with subcutaneous lesion
and/or no lesion in the liver were excluded. Spleens were harvested according to the same protocol as
that used in experiment 1, for both single spleen cell suspension and subsequent ﬂuorescence-activated
cell sorting (FACS) cell staining.
Total RNA extraction and qRT-PCR. Total RNA was isolated from spleen using the Qiagen RNeasy
minikit according to the manufacturer’s instructions. The quality of the isolated RNA was determined
with a NanoDrop ND 1000 (NanoDrop Technologies) and a Bioanalyzer 2100 (Agilent). Only samples with
a 260-nm/280-nm ratio between 1.9 and 2.1 and a 28S/18S ratio between 1.5 and 2 were further
processed. cDNA was synthesized using the Omniscript reverse transcription kit (Qiagen, Hilden, Ger-
many). SYBR green mix-based qRT-PCR was carried out on a Rotor-Gene 6000 qPCR detection system
(Corbett) with the FastStart Essential DNA Green Master (Roche, Basel, Switzerland) as per the manu-
facturer’s instructions. PCR cycling was performed in triplicates in ﬁnal volumes of 20 l containing 2 l
cDNA and 10 pM of each primer (cycle scheme: initial denaturation at 95°C for 15 min and 45 cycles of
95°C for 15 s, 55°C for 30 s, and 72°C for 30 s). Fluorescence was measured in every cycle, and a melting
curve was analyzed after the PCR by increasing the temperature from 55 to 95°C in 0.5°C increments. The
primers used were described earlier (5), and mRNA levels of different cytokines were quantiﬁed relative
to the mRNA level of housekeeping gene -actin.
Cell preparations and ﬂow cytometry. Spleen cells from naive (control) and E. multilocularis-
infected (AE) DEREG and WT mice were collected by grinding of spleens with 5 ml RPMI 1640 (Gibco).
Cells were subsequently washed twice and resuspended in RPMI 1640 for cell staining or cell culture.
Macrophages were removed from each group of mice by plastic adhesion as follows. Spleen cell
suspensions were incubated in 15 ml RPMI 1640–20% fetal calf serum (FCS) in a petri dish for 2 h at 37°C,
in humid atmosphere containing 5% CO2. Subsequent to incubation, nonadherent cells were separated
from macrophage-enriched adherent cells, and this new cell suspension was used for FACS analyses.
Aliquots of 106 cells/100 l of staining buffer per well were each incubated with 1 g of puriﬁed
anti-CD16/CD32 for 20 min in the dark in order to block nonspeciﬁc binding of antibodies to the FcIII
and FcII receptors. Subsequently, these cells were separately stained with the following surface markers
for 15 min with 1 g of primary antibodies: APC-labeled anti-CD4, anti-CD80, anti-CD86; phycoerythrin
(PE)-labeled anti-CD11b and anti-CD11c. All antibodies were from eBioscience (San Diego, CA, USA). For
intracellular staining, spleen cells were ﬁrst incubated with Inside Fix (Miltenyi Biotec, Bergisch Gladbach,
Germany) for 20 min at room temperature and subsequently stained with PE-labeled anti-IFN-, anti-IL-4,
anti-IL-17A, and anti-IL-10 (eBioscience, San Diego, CA, USA) in Inside Perm (Miltenyi Biotec, Bergisch
Gladbach, Germany) for 15 min in the dark. Corresponding ﬂuorochrome-labeled isotype control
antibodies were used for staining controls. Cells resuspended in 300 l of buffer (0.15 M NaCl, 1 mM
NaH2PO4·H2O, 10 mM Na2HPO4·2H2O, and 3 mM NaN3) were analyzed in a ﬂow cytometer (Becton
Dickinson, Heidelberg, Germany) using the corresponding Cell Quest software.
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Statistical analyses. All data were analyzed by SPSS 17.0. The results are presented as means 
standard deviations (SD). Normality of data was assessed by the D’Agostino & Pearson and Shapiro-Wilk
tests. For normally distributed groups of data, one-way analysis of variance (ANOVA) followed by
Bonferroni’s posttest was used to compare the differences between groups for cytokine gene expression
(experiment 1), and unpaired two-tail Student’s t test was used to compare the differences between
groups for the lesion number and size (experiment 2). Signiﬁcance was deﬁned at P values of 0.05 for
all tests except those with Bonferroni’s correction.
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